Navigation Links
The American Society of Interventional Pain Physicians Announces Guidelines for Responsible Prescribing of Pain-Killers for Chronic Non-Cancer Pain

NEW YORK, Aug. 1, 2012 /PRNewswire/ -- The American Society of Interventional Pain Physicians (ASIPP), a national medical society of over 4,000 members, has released its "Guidelines for Responsible Opioid Prescribing in Chronic Non-Cancer Pain." A multidisciplinary panel of 55 medical experts drafted this comprehensive two-part guideline to improve patient care, curtail the abuse of opioids without jeopardizing non-cancer pain management treatments, and improve understanding among law enforcement agencies, lawmakers, insurance providers and regulatory agencies.

Dr.  Laxmaiah Manchikanti, founder and CEO of ASIPP stated, "Opioid abuse has increased at an alarming rate since the 1990's and physicians must be proactive and take all necessary steps to ensure that their patients are properly assessed, diagnosed and monitored while receiving opioid treatment. This report provides clear and concise guidelines to improve patient access and avoid diversion and abuse."

In 2005, ASIPP published the first guidelines for prescribing opioids and the 2012 revised version was published in the July issue of Pain Physician, a high impact (IF 10.7) peer reviewed journal. Part 1 of the 2012 Guidelines reviews various aspects of opioid use, misuse, abuse, overuse and resulting fatalities.  It presents statements of best practice based on a thorough evaluation of evidence from published studies on treatments outcomes. Part 2 provides recommendations for initiation and maintaining of appropriate chronic opioid therapy for 90 days or longer.

The 2012 guidelines illustrate a 10-step process with comprehensive assessment and documentation process, establishing medical necessity and treatment goals, recommendations for responsible opioid therapy with dose limitations, and necessity for a comprehensive and robust patient agreement.

It also discusses adherence monitoring, evaluation of side effects and discontinuation or maintenance of opioid therapy on a long-term basis additionally the report covers the means and ways to initiate opioid therapy, specific guidelines for methadone use, and reduction in prescription drug dose.

About the American Society of Interventional Pain Physicians
ASIPP promotes the development and practice of safe, high-quality, cost-effective interventional pain management techniques for the diagnosis and treatment of pain and related disorders, and to ensure patient access to these interventions.   For more information, visit or call 270.554.9412. Ext. 215.

SOURCE American Society of Interventional Pain Physicians
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. American Academy of Family Physicians Foundation Launches Cities for Life
2. Interim results of VITOBA™ (VImpaT® added to One Baseline AED) Study Presented at the 64th Annual Meeting of the American Academy of Neurology
3. Elsevier Selected as New Publisher of The American Journal of Geriatric Psychiatry
4. Shire to Present Scientific Data Across Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting May 5-9
5. Data Presented at the American Psychiatric Association Annual Meeting Supports Gender-Specific Dosing of Intermezzo® (zolpidem tartrate) Sublingual Tablets CIV
6. New Data to be Presented at the Annual American Thoracic Society International Conference Demonstrates Depth of Boehringer Ingelheim Respiratory Research Pipeline
7. NVA237 Phase III GLOW2 Data at American Thoracic Society (ATS) International Conference and Phase II Clinical Trial Update
8. Pharmacyclics Announces Oral Presentations and Clinical Update of Ibrutinib (PCI-32765) at the 2012 Annual Meeting of the American Society of Clinical Oncology
9. Purdue Pharma L.P. To Present Analysis Of Butrans® (buprenorphine) Transdermal System CIII Clinical Data At American Pain Society Annual Meeting
10. Percutaneous Tibial Nerve Stimulation Included in the American Urological Associations Overactive Bladder Clinical Treatment Guidelines
11. Lilly Diabetes Presents Phase II Blood Pressure and Heart Rate Data on Investigational GLP-1 Analog Candidate, Dulaglutide, in Patients with Type 2 Diabetes at the 27th American Society of Hypertension Scientific Meeting
Post Your Comments:
(Date:12/1/2015)... -- Russia has always been a country ... drugs registered in Europe in 2015 were tested ... Russia has always been a country of choice for ... Europe in 2015 were tested in phase II-III ... has always been a country of choice for global multi-center ...
(Date:12/1/2015)... Dec. 01, 2015 ... "Veterinary Equipment and Disposables Market by product, ... report to their offering. --> ... "Veterinary Equipment and Disposables Market by product, by ... to their offering. --> Research and ...
(Date:12/1/2015)... , December 1, 2015 ... Contraceptive Injectables, Topical Contraceptives, Male Condoms, Female ... Vaginal Rings, Contraceptive Diaphragms, Contraceptive Sponges, Non-Surgical ... Size, Share, Growth, Trends and Forecast 2014 ... Transparency Market Research (TMR).The report states that ...
Breaking Medicine Technology:
(Date:12/1/2015)... ... ... Integrated Rental Services (“Integrated Rental”), a growing medical equipment ... With support from JII, Integrated Rental is poised for expansion while improving its ... labs and medical facilities across the United States. , General Manager Robert Bean ...
(Date:12/1/2015)... (PRWEB) , ... December 01, 2015 , ... Califia ... today announced that its iconic bottle has won top honors in Beverage World Magazine’s ... The Company also announced that it has been selected as a 2015 U.S.A. Taste ...
(Date:12/1/2015)... ... December 01, 2015 , ... December 1, 2015—Since the ... in scientific research and discoveries, leading us to better understand the disease’s behavior. ... those affected by HIV/AIDS. Mediaplanet’s cross-platform edition of “World AIDS Day” provides insight ...
(Date:12/1/2015)... ... December 01, 2015 , ... The importance of ... is the focus of numerous abstracts accepted for presentation here, at the 101st ... Nine abstracts highlight the use of Volpara Solutions’ quantitative breast imaging software tools ...
(Date:12/1/2015)... (PRWEB) , ... December 01, 2015 , ... ... that it has been selected as a finalist in this year’s Fierce Innovation ... FierceMobileHealthcare. Next IT Healthcare was recognized as a finalist in the category of ...
Breaking Medicine News(10 mins):